Drug Discovery and Development
For more than 40 years, drug discovery and development has been one of our core research activities. We work with pharmaceutical companies and government agencies to bring new medicines to market, and to ensure the safety and efficacy of those in the marketplace. Our in-depth experience, commitment to excellence, and state-of-the-art facilities make us a valuable resource for the following pharmaceutical client services:
- Drug Discovery
Our drug discovery group specializes in cancer and central nervous system drug research. Among our substantial achievements are the discoveries of the life-saving anti-cancer compounds Taxol® and camptothecin as well as other major products for a variety of clients. - Drug Development Services
We offer high-quality, non-clinical drug development services to the pharmaceutical, biotechnology, and chemical industries. Our integrated capabilities include drug metabolism and pharmacokinetics, toxicology, bioanalytical services, and analytical and formulation development services. - Clinical Research
We provide scientifically rigorous research and consulting services to pharmaceutical, biotechnology and medical device companies through RTI Health Solutions, a business unit of RTI International.
UMBI President Jennie Hunter-Cevera to Join RTI International as Executive Vice President of Discovery and Analytical Sciences, Corporate Development
Jennie Hunter-Cevera, Ph.D., a distinguished scientist, business leader and the current president and CEO of the University of Maryland Biotechnology Institute (UMBI), will join RTI International July 1, as Executive Vice President of Discovery and Analytical Sciences and Corporate Development.